ARTV vs GILD: Which Stock is Better?
Side-by-side comparison of Artiva Biotherapeutics Inc and Gilead Sciences Inc in 2026
ARTV
Artiva Biotherapeutics Inc
$10.80
GILD
Gilead Sciences Inc
$131.65
Key Metrics Comparison
| Metric | ARTV | GILD | Winner |
|---|---|---|---|
| Market Cap | $253.10M | $162.40B | GILD |
| P/E Ratio | N/A | 19.30 | GILD |
| EPS (TTM) | $N/A | $6.78 | GILD |
| Revenue Growth | -1.0% | 0.0% | GILD |
| Gross Margin | 0.0% | 78.8% | GILD |
Analyze ARTV
Full quant analysis
Analyze GILD
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is ARTV or GILD a better investment?
Comparing ARTV and GILD: Artiva Biotherapeutics Inc has a market cap of $253.10M while Gilead Sciences Inc has $162.40B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between ARTV and GILD?
ARTV (Artiva Biotherapeutics Inc) and GILD (Gilead Sciences Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: ARTV or GILD?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: ARTV or GILD?
GILD has higher revenue growth at 0.0% vs -1.0% for ARTV.
Which company is more profitable: ARTV or GILD?
Gilead Sciences Inc (GILD) has higher gross margins at 78.8% compared to 0.0% for ARTV.
Which is the larger company: ARTV or GILD?
Gilead Sciences Inc (GILD) is larger with a market cap of $162.40B compared to $253.10M for ARTV.
Should I buy ARTV or GILD in 2026?
Both ARTV and GILD have investment merit. ARTV trades at $10.80 while GILD trades at $131.65. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between ARTV and GILD stock?
Key differences: Market Cap ($253.10M vs $162.40B), P/E Ratio (N/A vs 19.3x), Revenue Growth (-1.0% vs 0.0%), Gross Margin (0.0% vs 78.8%).